Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
Switchpoint Bio has raised $5.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2026.
Switchpoint Bio is headquartered in Wilmington, United States.
Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
Switchpoint Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Switchpoint Bio — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/switchpoint-bio. Accessed August 14, 2026.
VCBacked. (2026). Switchpoint Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/switchpoint-bio
{{cite web |title=Switchpoint Bio — Funding & Investors |url=https://www.vcbacked.co/company/switchpoint-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated